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Abstract: Cancer is one of the major health issues with increasing incidence worldwide. In spite of
the existing conventional cancer treatment techniques, the cases of cancer diagnosis and death rates
are rising year by year. Thus, new approaches are required to advance the traditional ways of cancer
therapy. Currently, nanomedicine, employing nanoparticles and nanocomposites, offers great promise
and new opportunities to increase the efficacy of cancer treatment in combination with thermal
therapy. Nanomaterials can generate and specifically enhance the heating capacity at the tumor
region due to optical and magnetic properties. The mentioned unique properties of nanomaterials
allow inducing the heat and destroying the cancerous cells. This paper provides an overview of the
utilization of nanoparticles and nanomaterials such as magnetic iron oxide nanoparticles, nanorods,
nanoshells, nanocomposites, carbon nanotubes, and other nanoparticles in the thermal ablation of
tumors, demonstrating their advantages over the conventional heating methods.
Keywords: magnetic nanoparticles; gold nanoparticles; nanocomposites; nanorods; nanoshells;
carbon nanotubes; cancer tumor; thermal ablation; photothermal ablation; laser ablation
1. Introduction
Nowadays, cancer is the most serious health issue leading to the high rates of death worldwide.
According to the statistics from the World Health Organization, the number of cancer cases in 2018
increased to 18.1 million new cases and 9.6 million deaths. The leading types of new cancer cases
globally are lung, female breast, and colorectal cancers [1]. Therefore, the ability of early cancer detection
and treatment is of utmost importance. There are several well-known standard techniques for cancer
treatment such as surgery, radiation, and chemotherapy [2,3]. However, these methods cannot efficiently
fulfill the need in cancer disease treatment due to the several limitations such as the hard-to-reach
tumor position, the close location of other possible tumors, the patient’s opinion, and health conditions.
Moreover, cancer tumors can create protection from numerous chemotherapeutic agents, causing
additional obstacles for the treatment [4]. This review paper focuses on thermal ablation therapy to
outline the recent advances in cancer treatment by use of radiofrequency, microwave, laser ablation,
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and photothermal ablation sources supplemented by various nanomaterials. Moreover, the advantages
and properties of each nanomaterial, namely magnetic and gold nanoparticles, nanocomposites,
nanoshells, nanorods, carbon nanotubes, and other types of nanoparticles are discussed. A schematic
representation of several types of nanomaterials used is shown in Figure 1.
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Figure 1. Representation of different types of nanomaterials varied by a shape that can be used for
biomedical applications and cancer tumor treatment.
Thermal ablation is a technique used in cancer therapy to eliminate damaged cells or tissue
by applying external electromagnetic waves and elevated heat. Thermal ablation techniques utilize
radiofrequency, microwave frequency, and cryoablation, and is focused on ultrasound (US) and laser
light [5,6]. The advantages of thermal ablation therapy over the conventional methods are the flexibility,
low cost, and its minimal invasiveness [7]. However, the choice of a suitable heat delivery route
to the tumor is a vital and challenging concern in thermal ablation [8]. Moreover, existing heating
methods have difficulties in differentiatio betwee tumors and surrounding healthy tissues, leadi g
to the da age of t e neighboring cells [9]. Therefore, the combination of nanotechnology and thermal
therapy has attracted a lot of attention as a promising method to overcome the releva t limitations
of conventional thermal therapies. A schematic representation of nanomaterials and external heat
sources used is show in Figure 2.
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Figure 2. Schematic representation of cancer thermal therapy using the combination of nanomaterials
with various surface functionalization possibilities and different external heat sources.
t l is gaini g reat tten io in the biomedical field due to the possible ap lication
in diagn stics and treatment techniques [10–13]. Nanomaterials, especially nanoparticle -assist d nd
composite -a sisted thermal therapy, offer many advantages over c nventio al methods. Due to
their mag etic and optical prop rties, nanomaterials n t igger heat i cre s in tumor re ions by
absorbing ear-inf a d light (NIR), electromagnetic, or ra io frequency (RF) waves [14,15]. Moreover,
surface-functionalized nanomaterials can specifically bind to the cancer c ll nd llow selective heat
destruction of the tumor and also the multitasking possibility of cell separation and imaging [16,17].
As hown in Figur 3, the nanomaterials allow heat increase at the sp cific region and prevent the eat
gen ration in the non-tar eted region, improving h s lectivity of the treatm nt.
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Figure 3. Thermal hypothermia of a tumor using nanoparticles enclosed inside of it absorbing the energy
coming from different heat sources. NPTT—Nano-Photothermal Therapy, NMH—Nano-Magnetic
Hyperthermia, NaRFA—Nano-Radio-Frequency Ablation, NUH—Nano-Ultrasound Hyperthermia
[Reproduced from [8], with permission from Elsevier, Copyright 2016].
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A general procedure for the RF thermal ablation combined with nanomaterials consists of the
following stages: the specific and selective attachment of nanoparticles with cancer, validation of
binding, and heat administration to the specific area by applying an electromagnetic field [18]. However,
in order to have safe tumor destruction, parameters such as the critical heat dose, application of proper
magnetic material concentration, and its biodistribution are vital [19–21]. In addition, the further
removal of the nanomaterial from the targeted area should be considered carefully in order to avoid
the undesired heating of non-target tissue [20].
The size and shape of nanoparticles are critical factors that determine their performance: the
ability to penetrate the blood vessel, reach the targeted region, affect the rate of macrophage uptake,
and finally wash out from the body. For instance, nanoparticles larger than 10 nm will be too large
to pull out from the normal capillaries [22,23]. In addition, the transport of smaller nanoparticles
exhibits relatively higher diffusion rates, which allows them to move laterally in the blood vessel
with greater ease. However, larger particles can penetrate the tumor through the gaps between the
endothelial cells in leaky tumor vasculature and remain there for a long time. This phenomenon called
the enhanced permeability and retention (EPR) effect. Mainly, the EPR effect is beneficial to deliver
the nanoparticles loaded with the drug. The larger nanomaterials can permeate and accumulate at
the tumor site for a long time, causing the effective treatment and avoiding the side effects that are
due to failure to penetrate the normal tissue. The drawback of the EPR effect is the inhomogeneity of
interstitial holes, which affects the uniform penetration and distribution of nanoparticles within the
tumor [24,25]. Nanoparticles of different shapes have a different active fractional area, which results in
variability in binding avidity, circulation in the blood, and the ability to bind to wall receptors (Figure 4).
Thus, the nanoparticle shape affects the rate of tumor deposition and therapeutic efficacy [23].
Nanomaterials 2019, 9, x FOR PEER REVIEW 4 of 35 
 
NUH—Nano-Ultrasound Hyperthermia [Reproduced from [8], with permission from Elsevier, 
Copyright 2016]. 
A general procedure for the RF thermal ablation combined with nanomaterials consists of the 
following stages: the specific and selective attachment of nanoparticles with cancer, validation of 
binding, and heat administration to the specific area by applying an electromagnetic field [18]. 
However, in order to have safe tumor destruction, parameters such as the critical heat dose, 
application of proper magnetic material concentration, and its biodistribution are vital [19–21]. In 
addition, the further removal of the nanomaterial from the targeted area should be considered 
carefully in order to avoid the undesired heating of non-target tissue [20].  
The size and shape of nanoparticles are critical factors that determine their performance: the 
ability to penetrate the blood vessel, reach the targeted region, affect the rate of macrophage uptake, 
and finally wash out from the body. For instance, nanoparticles larger than 10 nm will be too large to 
pull out from the normal capillaries [22,23]. In addition, the transport of smaller nanoparticles 
exhibits relatively higher diffusion rates, which allows them to move laterally in the blood vessel 
with greater ease. However, larger particles can penetrate the tumor through the gaps between the 
endothelial cells in leaky tumor vasculature and remain there for a long time. This phenomenon 
called the enhanced permeability and retention (EPR) effect. Mainly, the EPR effect is beneficial to 
deliver the nanoparticles loaded with the drug. The larger nanomaterials can permeate and 
accumulate at the tumor site for a long time, causing the effective treatment and avoiding the side 
effects that are due to failure to penetrate the normal tissue. The drawback of the EPR effect is the 
inhomogeneity of interstitial holes, which affects the uniform penetration and distribution of 
nanoparticles within the tumor [24,25]. Nanoparticles of different shapes have a different active 
fractional area, which results in variability in binding avidity, circulation in the blood, and the ability 
to bind to wall receptors (Figure 4). Thus, the nanoparticle shape affects the rate of tumor deposition 
and therapeutic efficacy [23]. 
 
Figure 4. Effects of shape on nanoparticle flow. Spherical nanoparticles move toward the center of 
the flow, while the rod-shaped nanoparticles tend to attach to wall receptors due to the different 
forces and torques exerted on rods. 
Moreover, the surface-chemical properties of nanoparticles and their surface coating play a 
crucial role in further attachment to the cancer cells. Notably, the functional groups on the surface of 
the nanoparticle are considered as the defining factors of solubility, interaction, and attachment to 
the cell. Depending on the surface coating, nanoparticles can be defined as positively or negatively 
charged. Positively charged nanoparticles are the most beneficial in the passage of cell-membrane 
barriers, and concentrate in the cytosol or nucleus [26].  
The control of heat delivery and dose to the cancerous cells is significant in order to meet the 
clinical requirements. The specific absorption rate (SAR) was found as the main factor to estimate the 
heating of the tissue generated by the magnetic induction. This parameter is proportional to 
temperature increase, which is defined as the electromagnetic energy absorption rate by a unit mass 
Figure 4. Effects of shape on nanoparticle flow. Spherical nanoparticles move toward the center of the
flow, while the rod-shaped nanoparticles tend to attach to wall receptors due to the different forces and
torques exerted on rods.
oreover, the surface-chemical properties of nanoparticles and their surface coating play a crucial
role in further attachment to the cancer cells. Notably, the functional groups on the surface of the
nanoparticle are considered as the defining factors of solubility, interaction, and attachment to the cell.
Depending on the surface coating, nanoparticles can be defined as positively or negatively charged.
Positively charged nanoparticles are the most beneficial in the passage of cell-membrane barriers,
and concentrate in the cytosol or nucleus [26].
The control of heat delivery and dose to the cancerous cells is significant in order to eet the
clinical require ents. The specific absorption rate (SAR) was found as the main factor to estimate
the heating of the tissue generated by the magnetic induction. This para eter is proportional to
te perature increase, which is defined as the electromagnetic energy absorption rate by a unit mass of
biological material, and is defined as follows as in Equation (1), where λ—the thermal conductivity of
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the tissue, c—the concentration of nanoparticles, ∆T—the required temperature increase, and R—the
radius of the spherical tumor [27,28].
SAR =
∆ T × 3λ
c×R2 (1)
Sapareto and Dewey [29] studied the thermal dosimetry of thermo-therapies, the effect of high
temperature, and the duration of exposure in cancer cells. This model is now commonly used in
electrical thermo-therapies such as Radiofrequency ablation (RFA) and Microwave ablation (MWA) [30].
Laser ablation studies are often performed on phantoms that mimic the absorption properties of lasers
in the infrared [31]. Most phantoms are based on agar jelly with blackened colorants that are designed
to match the absorption and anisotropy coefficients of human tissues [32]. Nowadays, colorimetric
models are also used in RFA and MWA in order to have phantoms that are able to yield a different
color as a function of the peak temperature achieved during rapid ablation phenomena. A recent work
has been presented by Mikhail et al. [33], who reported a thermo-chromic phantom for RFA made of
polymeric materials.
Beik et al. presented a review of breakthroughs in nanotechnology for hypothermia cancer therapy.
The paper presented the results in nano-photothermal therapy, nano-radio-frequency ablation therapy,
nano-US hypothermia therapy, and nano-magnetic hyperthermia therapy employing magnetic and
gold nanoparticles [8]. The focus of Beik et al. was on radiation sources rather than nanoparticle
types. Abadeer et al. [34] conducted a review on the recent progress in cancer thermal therapy
using gold nanoparticles. This work included in vitro and in vivo studies and the recent advances
of gold nanoparticle photothermal therapy toward clinical cancer treatment. The potential of RF
hyperthermia using gold nanoparticles has been investigated and demonstrated as effective under
certain conditions, and the treatment may merit further study. Many researchers have also demonstrated
effective cancer treatment, at least in the lab, with photothermal therapy [34]. Day et al. reviewed the
application of magnetic nanoparticles, nanoshells in near-infrared photothermal therapies, magnetic
fluid hyperthermia, and RF ablation [9].
The major difference of this review paper compared to others is in the extended investigation
of frequently used nanomaterials (magnetic nanoparticles, gold nanoparticles, CuS nanoparticles,
nanorods, carbon nanotubes, nanoshells, and nanocomposites) applied in the cancer thermal therapy
using radiofrequency (RF), microwave (MW), photothermal and laser therapy.
2. Magnetic Nanoparticles (MNP)
MNP is a widely used nanomaterial type in thermal therapy with a size range between 1–100 nm.
MNPs comprise magnetic elements, such as cobalt, manganese, nickel, iron, chromium, calcium,
and gadolinium. Among various MNPs, the iron oxide nanoparticles are widely used in thermal ablation
therapy due to the high value of the magnetic moment density, which is 220 emu/g. Moreover, iron oxide
MNPs are biocompatible compared to other MNPs, which are known as toxic and susceptible to
oxidation [35]. Figure 5 shows that MNPs are mostly spherical in shape when analysed in Transmission
Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM).
Iron oxide nanoparticles according to their structure are classified as hematite (α-Fe2O3),
maghemite (γ-Fe2O3), and magnetite (Fe3O4) nanoparticles (Figure 6). Nanoparticles made up of
ferromagnetic materials and less than 10–20 nm in size display a unique type of magnetism, which is
called superparamagnetic [36]. The phenomenon of superparamagnetism involves magnetization up to
saturation magnetization when an external magnetic field is applied, and can return to a nonmagnetic
state when the external magnet is removed. This property of nanoparticles occurs in single-domain
magnetic particles and depends on the size, which should be as low as 10–30 nm [37].
Among iron oxide nanoparticles, Fe3O4 and γ-Fe2O3 exhibit ferrimagnetism at room temperature,
leading to the possibility of application in magnetic thermal therapy [38]. The magnetite particle has
an inverse spinel configuration with the tetrahedral A-sites and the octahedral B-sites. The A-sites
of magnetite structure are occupied by Fe3+ ions, and the B-sites are occupied by Fe2+ and Fe3+ ions.
Nanomaterials 2019, 9, 1195 6 of 35
This explains the idealized magnetic moment of Fe3O4, which is 4 µB per formula unit. The structure
of MNPs is one of the key aspects that makes the extensive adaptation of magnetic thermal ablation
possible [39].
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Figure 6. Crystal structure and crystallographic data of the hematite (a), magnetite (b), and maghemite
(c) (the black ball is Fe2+, the green ball is Fe3+, and the red ball is O2). [Reproduced from [38],
with permission by license CC BY 3.0, Copyright 2015].
MNPs can produce heat by four distinct mechanisms: eddy currents and hysteresis losses
in particles with sizes greater than 1 micron, relaxation losses in superparamagnetic particles,
and frictional losses in suspensions that are viscous [40,41]. Relaxation losses can be defined by
two mechanisms: the Neel relaxation mechanism and the Brownian motion of the particles. The Neel
relaxation mechanism is a rotation of the magnetic moment within a nanoparticle, which remains
fixed. The dissipation of e ergy during the Neel relaxation occurs by rearranging of the atomic dipole
moment in cry tal. While in Brownian motio , the entire nanoparticle ro ates within its surroundings,
dissip ting the thermal en rgy to the a bient medi through hear stress (Figure 7). The dissipation of
magnetic energy of nanoparticle into thermal energy is reasoned by the property of particles to change
the orientation of the magnetic moment to align with the field and return to the equilibrium position
when an alternating magnetic field (AMF) is applied [42–44].
The first groundbreaking research in the utilization of magnetic materials for the enhancement
of the thermal therapy was done by Gilchrist et al. in 1957. They experimentally demonstrated on
a dog’s lymph nodes that t field streng h of 200 to 240 Oersteds with 5 mg of 20–100-nm sized
Fe2O3 nanoparticles per gr m of tissue could increase the t mperature by 14 ◦C in three minutes by
applying RF heating [45]. Later, in 1965, the same group obtained the elimination of metastasis at
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50 ◦C temperature for 30 min in 15 dogs utilizing the ferrite magnetite nanoparticles that were between
20–100 nm µm [46]. After these studies, many investigations in these field have been done to optimize
cancer treatment techniques.
Nanomaterials 2019, 9, x FOR PEER REVIEW 7 of 35 
 
mechanisms: the Neel relaxation mechanism and the Brownian motion of the particles. The Neel 
relaxation mechanism is a rotation of the magnetic moment within a nanoparticle, which remains 
fixed. The dissipation of energy during the Neel relaxation occurs by rearranging of the atomic 
dipole moment in crystal. While in Brownian motion, the entire nanoparticle rotates within its 
surroundings, dissipating the thermal energy to the ambient media through shear stress (Figure 7). 
The dissipation of magnetic energy of nanoparticle into thermal energy is reasoned by the property 
of particles to change the orientation of the magnetic moment to align with the field and return to the 
equilibrium position when an alternating magnetic field (AMF) is applied [42–44]. 
 
Figure 7. The Neel relaxation and Brownian mechanism representation of heat generation via MNPs 
under the atomic magnetic moment [Reproduced from [8], with permission from Elsevier, Copyright 
2016]. 
The first groundbreaking research in the utilization of magnetic materials for the enhancement 
of the thermal therapy was done by Gilchrist et al. in 1957. They experimentally demonstrated on a 
dog’s lymph nodes that the field strength of 200 to 240 Oersteds with 5 mg of 20–100-nm sized Fe2O3 
nanoparticles per gram of tissue could increase the temperature by 14 °C in three minutes by 
applying RF heating [45]. Later, in 1965, the same group obtained the elimination of metastasis at 
50 °C temperature for 30 min in 15 dogs utilizing the ferrite magnetite nanoparticles that were 
between 20–100 nm µm [46]. After these studies, many investigations in these field have been done 
to optimize cancer treatment techniques. 
MNPs can be produced by different chemical and physical synthesis techniques, which can 
influence the final parameters of the nanoparticles [47]. Notably, the method of nanoparticle 
synthesis affects the final size, shape, and/or surface charge of the final product. The size of MNPs is 
one of the significant parameters in the thermal therapy. As the size of nanoparticles decreases, the 
surface-to-volume ratio increases, offering a wide range of optical, electronic, chemical, and 
magnetic properties [48]. Furthermore, MNPs with small sizes and high surface areas are 
biocompatible, biodegradable, chemically stable, easy to synthesize, and cost-effective [49,50]. 
Superparamagnetic iron particles with core diameters less than 6 nm are not able to generate heating 
properties. Therefore, it is preferred to have particles with a size larger than 10 nm to reach the 
cytotoxic effects within target cells and the possibility of heat increase [51]. Moreover, Tong et al. in 
their study defined that MNPs with sizes larger than 15 nm have better heating efficiency. However, 
the size limits up to 40-nm MNPs, because at this point, the SAR value reaches the theoretical 
maximum of clinically significant AMF [52]. Many studies employed MNPs that were 10–20 nm to 
investigate the heat increase at the tumor site [20,51,53–58]. In the study of Hilger et al., three MNP 
samples with 10-nm and 220-nm sizes were employed in the thermal therapy; the maximum 
i r . The Neel rel xation and Brow ian mechanism representation of heat generation via
MNPs under the atomic magnetic moment [Reproduced from [8], with pe mission from Elsevier,
Copyright 2016].
MNPs can be produced by different chemical and physical synthesis techniques, which can
influence the final parameters of the nanoparticles [47]. Notably, the method of nanoparticle synthesis
affects the fi al size, shape, and/or surface charge of the final product. The size of MNPs is
one of the significant parameters in the thermal t erapy. As the size of nanoparticles decreases,
the surface-to-volume ratio increases, offering a wide range of optical, electronic, chemical, and magnetic
properties [48]. Furthermore, MNPs with small sizes and high surface areas are biocompatible,
iodegradable, chemically stable, easy to synthesize, and cost-effective [49,50]. Superparamagnetic
iron particles with core diameters less than 6 nm are not able to generate heating properties. Therefore,
it is preferred to have particles with a size larger than 10 nm to reach the cytotoxic effects within target
cells a d the possibility of heat increase [51]. Moreover, Tong et al. in their study defined that MNPs
with sizes larger than 15 nm have better heating efficiency. However, the size limits up to 40-nm
MNPs, because at this point, the SAR value reaches the theoretical maximum of clinically significant
AMF [52]. Many studies employed MNPs that were 10–20 nm to investigate the heat increase at the
tumor site [20,51,53–58]. In the study of Hilger et al., three MNP samples with 10-nm and 220-nm sizes
were employed in the thermal therapy; the maximum temperature of 73 ◦C was obtained by 10-nm
MNPs, while the 220-nm MNPs could increase the heat up to only 50 ◦C [20].
MNPs found wide application in the treatment of breast, prostate, glioblastoma, kidney, etc. Most
researchers concentrated their study o specific cell types. For instance, Hilger et al. focused mainly o
t e thermal ablation t erapy of breast cancer employing magnetic nanoparticles, and demonstrated the
possibility of electromagnetic heating of breast c ncer tumors with volumes of approximately 300 mm3,
utilizing 10 female immunodeficient mice and injecting intratu orally 50–100 µL of magnetite fluid at
a flowrate of 50 µL/min. For the magnetic thermoablation of tumors, the mice were exposed to an
AMF (frequency, 400 kHz; amplitude, 6.5 kA/m) for 242 s. Over t e treat ent, a mean temperature of
71 ± 8 ◦C and a maximum temperature of 79 ◦C were recorded [53]. In another in vivo study by the
same group, the thermal ablation procedure of breast cancer using a greater number of mice—exactly
45 mice divided into three iron oxide MNP models by size—was conducted to observe the deposited
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heat dosage on cell death at different regions of the tumor. The experimental set up demonstrated the
higher temperature increment at the center of the tumor (73 ◦C) compared to the periphery region
(12 ◦C) when applying an alternating current at a frequency of 400 kHz and amplitude of 6.5 kA/m,
leading to the conclusion that magnetite nanoparticles mostly concentrated at the tumor center [20].
Another in vitro study of breast cancer treatment using MNP was performed by Kettering et al.,
concentrating also on BT-474 cells [51].
Johannsen et al. conducted a broad investigation of the thermal ablation of prostate cancer tumor,
specifically MatLyLu (the R3327 Dunning tumor cell) tumor model using MNPs [56–58]. In phase
I clinical studies, Johannsen et al. demonstrated the increase of temperature up to 55 ◦C. However,
in some patients, the temperature was recorded as 44 ◦C at the skin. This research showed the possible
clinical challenges of thermal therapy using MNPs. The difficulties of prostate cancer treatment
are explained by the high perfusion of this organ, restrained obtainable temperatures, and thermal
homogeneity. Adding to these reasons, the prostate is concealed anteriorly by bone and fat and
encompassed by hollow organs enclosing fluid and air. The various conductivities of these tissues
to RF or US waves utilized for heating objectives can trigger unwanted reflection, scattering, or the
absorption of thermal energy outside the target region in critical areas [57].
An in vivo study of thermal therapy of glioblastoma multiforme of rat glioma cells (RG-2 cells)
using MNPs in 120 rat models was proposed by Jordan et al. Glioblastoma is mainly a brain tumor with
high death and low survival rates [55]. The difficulties of brain tumor treatment caused by the several
challenges: the location of tumor can be hard to reach, the brain has unique biological features being
sensitive to neural mechanisms, and the tumor can be positioned behind the blood–brain barrier [59,60].
Another research group clinically investigated the efficacy of the thermal therapy in combination
with radiotherapy in a phase II study of 66 patients with recurrent glioblastoma multiforme using
112 mg/mL of 12-nm amino-silane coated MNPs. The three-month post-treatment monitoring of
patients showed an increase in the overall survival rate [61].
Bruners et al. conducted research on the computed tomography (CT)-guided magnetic thermoablation
of animals with kidney tumors using a rabbit VX2 carcinoma model in vivo and colloidal superparamagnetic
magnetite particles. Exposure to the electromagnetic field was maintained for 15 min with the value
of frequency of 56 kHz, inducing an electromagnetic field with a strength of about 0.32 kA/m.
The CT-guided injection of nanoparticles demonstrated the inhomogeneous distribution of the injected
ferrofluids, and the optimal method of ferrofluid application is still under investigation [62].
Coating the surface of the nanoparticles by functional groups provides a great opportunity for
the application of MNPs in biomedicine, namely in drug delivery, cell sorting, separation, tissue
repair, and magnetic resonance imaging [51]. Depending on the cancer type, the nanoparticles
can be functionalized with antibodies, DNA, polymers, proteins, liposomes, or other ligands to
attach specifically and selectively to the tumor region. Moreover, the surface coating prevents the
agglomeration of nanoparticles and allows reducing the toxicity of bare nanoparticles [63]. Hilger et al.
conducted the research for the in situ and multi-focal treatment of breast cancer tumors to observe the
cell death rate during thermal ablation when magnetites and maghemite coated with dextran were
used. This research showed that an intratumoral application of MNPs with an iron concentration up
to 107 pg/cell could raise the temperatures up to around 71 ◦C at the center of the tumor in 242 s at
a frequency range of 400 kHz and 6.5 kA/m field amplitude. Moreover, the accumulation and attachment
of dextran-coated nanoparticles to the breast cancer can be monitored by magnetorelaxometry or—in
the case of an in vivo study—by magnetic resonance tomography. This research demonstrated
that a multi-focal tumor causes higher complexity during thermal ablation and requires further
investigation [54]. Kettering et al. utilized the MNPs with a starch coating to label with the adherent
invasive ductal breast carcinoma cell line BT-474 cells at 0.32 mg Fe mL−1 concentration. The heat
elevation in cells labeled with MNPs was checked by varying the following parameters: a various
concentration of cells (0.5, 1, 2.5 and 5 × 107 BT-474 cells mL−1), different incubation times (1, 3, 6, 12,
and 24 h) and varied concentrations of nanoparticles (0.16, 0.32 and 0.48 mg Fe, respectively, per mL of
Nanomaterials 2019, 9, 1195 9 of 35
culture medium for 24 h). The MNP-labeled cells were exposed to an AMF with a frequency range
of 400 kHz and an amplitude of 24.6 kA m−1. The highest temperature value of 28.2 ± 0.4 ◦C was
observed when cells were labeled with 0.32 mg Fe mL−1 culture medium for 24 h and a concentration of
2.5 × 107 BT-474 cells mL−1. The research demonstrated the possibility of increasing the concentration
of MNPs at the tumor region by labeling with cells through surface functionalization [51].
Jordan et al. performed the in vivo thermal therapy of 120 male rats with RG-2 glioma cells
at a frequency of 100 kHz and a variable field strength of 0–18 kA/m using MNPs with two types
of coatings—carboxydextran-coated and amino-silane coated—in order to observe the relevance of
the surface coating on intratumoral temperature homogeneity. The nanoparticles with two types
of coatings demonstrated different performances regarding their distribution within the specific
region, leading to distinct temperatures for intratumor therapy. Amino-silane coated nanoparticles
exhibited homogeneous distribution in the tumor area during heating procedures, and the intratumoral
temperatures reached 43 ◦C and 47 ◦C by altering the magnetic field strength. The dextran-coated
nanoparticles demonstrated an insignificant increase in temperature of only 2 ◦C [55]. Another study
using amino-silane coated MNPs for the thermal therapy of glioblastoma multiforme also demonstrated
positive results and a higher survival rate [61].
Johannsen et al. in 2005 proposed an in vivo study of the magnetic fluid thermal ablation of
prostate cancer MatLyLu cells using magnetic ferrofluids with an average particle core size of 15 nm
that were coated with an amino silane-type shell in water. Compared to previous studies, this research
demonstrated an increase of temperature above 70 ◦C and a significant reduction of local tumor
growth in the orthotopic MatLyLu tumor model of prostate cancer [58]. Later in 2007, the same
group demonstrated the possibility to achieve thermoablative temperatures with 15-nm core and
amino-silane coated MNPs in the prostates utilizing low magnetic field strengths. The nanoparticles
with a concentration of 112 mg/m in aqueous liquid were injected transperineally and exposed to the
AMF with the frequency range of 100 kHz, and field strength varied from 2.5 to 18.0 kA/m. This research
defined an approach for a non-invasive temperature evaluation strategy using distributions of MNPs
to predict the distribution of a three-dimensional intraprostatic temperature in each patient [56].
The further preclinical studies proposed the contactless, selective heating of superficial tumors on
10 patients with biopsy-proven, locally recurrent prostate cancer. The amino-silane-type shell-coated
nanoparticles with an average core size of 15 nm were injected transperineally into the prostates.
Six thermotherapy sessions were delivered at weekly intervals using an AMF with a frequency of
100 kHz and variable field strength (2.5–18 kA/m). The maximum temperatures reached 55 ◦C at 25–30%
of the magnetic field strength available [64]. Balivada et al. demonstrated the antitumor potential of
the modified bimagnetic core-shell of stealth-coated dopamine-labeled Fe/Fe3O4 nanoparticles with the
size of 7.2 ± 2.8 nm intratumorally injected on murine B16-F10 melanoma with three short 10-minute
AMF exposures in mice over 14 days. This study revealed a significant decrease in tumor weight using
the Fe/Fe3O4 nanoparticles [65].
The distribution of nanoparticles within the tumor area is a crucial point in thermal therapy in
order to obtain homogeneous heating. Richter et al. proposed the use of magnetorelaxometry (MRX) as
an appropriate instrument to monitor the MNP distribution quantitatively with less contact. In another
study, 200 µL of a 200-nm MNP suspension was injected into the tumor of female Severe Combined
Immune-Deficient (SCID) mice. The quantification results by multichannel MRX show that 24 h after
intratumoral MNP injection, all the administered MNPs were found in the tumor site. This research
demonstrated the possibility of quantitative controlling the distribution of distribution within the
tumor area during the magnetic ablation [66]. Finally, Andra et al. performed spatial temperature
distribution by means of a mathematical simulation. This research demonstrated an experimental
study satisfying the numerically simulated studies at 6.5 kA/m amplitude and 400-kHz frequency of
the applied field. However, the results were restricted to small tumors [67].
Table 1 presents a summary of MNPs application in thermal ablation therapy, demonstrating the
general ablation conditions, type of cancerous cells and the increase of temperature.
Nanomaterials 2019, 9, 1195 10 of 35
Table 1. Summary of MNPs application in thermal ablation of cancer.
Type of MNP/MNP
with a Surface Coating
Nanoparticle
Size
Injection
Dose/Nanoparticle
Concentration
Injection
Route Exposure Conditions
Thermal
Ablation Type Type of Tumor Temperature,
◦C CellDeath Reference
Fe3O4 20–100 nm
5 mg of Fe2O3 per gram
of tissue intratumoral
200 to 240 oersteds,
3 min RF ablation dog’s lymph nodes max 50
◦C N/A [45]
Fe3O4 50–100 nm
5 mg of Fe2O3 per gram
of tissue intratumoral
55,000 cycles/second,
500 oesterds, 30 min RF ablation
lymph node
metastases by max 50
◦C N/A [46]
Fe3O4 10–20 nm
21 mg ± 9 of magnetite
per 299 mm3 of tumor
tissue
intratumoral 1.2–6.5 kA/m;400 kHz, 242 s AMF human breast tissue max 79
◦C N/A [53]
Fe3O4 10 nm
5 ± 0.3 mg magnetite
per 100 mg of tumor
tissue
intratumoral 400 kHz,6.5 kA/m, 4 min AMF
human breast
adenocarcinoma
cells
max 73 ◦C at tumor
center and 12 ◦C at
tumor periphery
N/A [20]
Fe3O4—dextran coated 10–20 nm 107 pg/cells intratumoral
410 kHz,
10 kA/m, 242 s AMF
human breast
adenocarcinoma
cells
max 71 ◦C at tumor
center N/A [54]
Fe3O4—starch coated 11.4 nm ± 0.38 0.32 mg Fe mL
−1
culture medium
intratumoral 400 kHz, 24.6 kA m−1 AMF breast carcinoma cellline BT474 to 28.2 ± 0.4
◦C N/A [51]
Fe3O4—amino-silane
coated 15 nm N/A intratumoral 100 kHz, 0–18 kA/m AMF RG-2 glioma cells max 43–47
◦C N/A [55]
Fe3O4 20 nm
11.4 mL per 100 mg of
tumor tissue interstitial 100 kHz, 2.5–15 kA/m AMF prostate cancer max 55
◦C N/A [57]
Fe3O4—amino-silane
coated 15 nm 112 mg/mL transperineally
100 kHz,
2.5–18.0 kA/m, 60 min AMF prostate cancer max 50
◦C N/A [56]
Fe3O4—amino-silane
coated 15 nm
200–400 µl of MNP
per 0.5 mL/cm3 tumor
volume
and 120 mg/mL
intratumoral 100 kHz, 18.0 kA/m AMF prostate cancer
max 54.88 ◦C
centrally and
41.28 ◦C—peripherally
N/A [58]
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3. Gold Nanoparticles (AuNP)
In recent years, AuNPs are actively employed in biomedical applications. AuNPs are known as
the most stable metal nanoparticles and can be easily synthesized in different shapes [68]. In addition,
AuNPs have tunable optical properties, flexible surface chemistry, and a broad range of functionalization
possibilities by antibodies, peptides, and polymers for application in various fields. Moreover, one of
the main advantages of AuNPs is the ability to convert the light or RFs into heat, owing to the surface
plasmon resonance phenomenon of gold, which enables their use in thermal ablation therapy [69–71].
A TEM image of spherical AuNP is presented in Figure 8.
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AuNPs are mainly used in the thermal treatment of cancer, employing RF ablation and laser
photothermal ablation. The distinction between conventional hyperthermia and photothermal therapy
is that during photothermal heating, the increase of heat occurs around the AuNPs, leading to the rise
of local temperatures to tens or hundreds of degrees above physiological temperature [9].
The size of AuNPs used for thermal ablation varied between 5–40 nm, depending on the type
of ablation and cell line. Smaller AuNPs are preferred in cancer thermal therapy because light is
absorbed by nanoparticles, which affects the valuable cell destruction when converted to heat [69].
Moreover, smaller particles have higher surface area-to-volume ratios, providing more opportunities
for biological elements or proteins to attach to the particles’ surfaces. Finally, the smaller particles can
be easily removed from the human vasculature. The shape, cell type, and surface coating along with
the size are vital parameters for the cancer cells’ destruction using AuNPs. This review presents the
use of AuNPs in the treatment of epithelial carcinoma, liver cancer with hepatocellular (HepG2 and
Hep3B) cancer cell lines, and pancreatic cancer with a human pancreatic cancerous cells (Panc-1) and
human pancreatic ductal adenocarcinoma cell line (Capan-1) [69,72–76].
Notably, the possibility of gold surface functionalization is beneficial to differentiate between
cancerous and healthy cells to specifically attach the AuNPs to the desired tumor region. Furthermore,
the coating of the AuNPs’ surface is important in order to make the nanopartciles selective to the specific
cancer and effective in thermal treatment, and also to limit their toxicity level. One of the frequently
used ligands to conjugate with AuNPs and employ further in thermal therapy is an anti-EGFR antibody
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(epidermal growth factor receptor), which is responsible for the cell transduction mechanisms in
ordinary and cancer cells. The choice of anti-EGFR antibody conjugation for the labeling of cells
with AuNPs is reasoned by EGFR overexpressing in most tumor cells [77]. In the study performed
by El-Sayed et al., the laser photothermal therapy of the epithelial carcinoma HaCaT cells (human
keratinocyte cell line) was carried out using an anti-EGFR antibody conjugated to AuNPs with the
average particle size of 40 nm at 530-nm absorption maximum. The photothermal stability of AuNPs
was investigated by exposing the cells to the different densities of the laser power such as 64, 57, 51, 45,
38, 32, 25, 19 and 13 W/cm2 at various points for 4 min. This research showed that the HaCaT cells after
incubation with the anti-EGFR antibody-conjugated AuNPs can cause the complete destruction of
the tumor at a laser density higher than 57 W/cm2 compared to control groups of two oral squamous
carcinoma cell lines (HSC 313 (Hematopoietic stem cell) and HOC 3 (Cellosaurus cell line) ). The study
demonstrated not only the importance of the nanomaterial surface functional groups, but also the
value of the laser power density [72].
The research conducted by Huang et al. also demonstrated the beneficial selective kill of cancerous
cells using AuNPs coated with anti-EGFR. The laser photothermal therapy of cancerous cells showed
the death of cancerous cells at much lower laser powers than those needed for healthy cells—200 nW
compared to 750 mW, respectively—and less dosage requirement. The study showed that a threshold
temperature in the range of 70 to 80 ◦C is required to destroy cancerous as well as noncancerous cells,
which complies with the data of previously conducted research studies [78]. Another study with
20-nm sized anti-EGFR functionalized AuNPs was performed by the group of Glazer et al. for the RF
heating (13.56 MHz, 200 S, 10−15 kV/m, 5 min) of pancreatic cancer. The research investigated the
importance of surface chemistry by comparing the cell lines overexpressing and not expressing the
EGFR, which are Panc-1 and Cama-1, respectively. Finally, a 61% decrease in viability was observed
for Panc-1 compared to the control Cama-1 cell line, which reached only 6.3% decrease [76].
A further clinical in vivo investigation of the thermal therapy of pancreatic cancer was done by
the same group,where two human pancreatic carcinoma cell lines were exposed to the RF field, Panc-1
and Capan-1, utilizing PAM4 hemi-antibody conjugated and C225 antibody conjugated with 20-nm
sized AuNPs. The hydrodynamic diameter of the C225-AuNP is 32.6 ± 0.7 nm, while it is 36.9 ± 1.5 nm
for PAM4-AuNP. C225-conjugated AuNPs have been more efficient in destroying targeted tumors
than PAM4-conjugated AuNPs. However, C225 as a targeting agent can have more negative clinical
occurrences due to the increased absorption of AuNP in non-malignant tissues. PAM4 appears to be
much more specific to pancreatic cancer, and only works as a pancreatic adenocarcinoma that targets
an antibody without an intrinsic cytotoxicity or growth inhibition characteristics [75].
The cytotoxicity effects of AuNPs was also investigated by other research group on non-invasive
RF ablation hepatocellular (Hep3B) and pancreatic cancerous cells (Panc-1) at 13.56 MHz employing
5-nm sized AuNPs with 67 µM/L concentration. The cytotoxicity parameter is vital for the further use
of nanoparticles in clinical purposes. The authors reported the absence of the intrinsic cytotoxicity of
AuNP, and the range of malignant cell destruction was 99.8 ± 3.1% for Hep3B cell death and 96.5 ± 8.4%
for Panc-I cell death in 5-min exposure [74].
The significance of RF field power on thermal therapy was explored by Cardinal et al. This group
studied the non-invasive RF ablation of liver cancer with HepG2 cancerous cells employing 13-nm
citrate coated AuNPs. To determine the effect of RF field power on heating, solutions were exposed to
the RF field at variable powers from 10 W to 100 W for 3 min. The obtained data demonstrated the
ability of heat elevation for more than 50 ◦C by AuNP-containing solutions. Moreover, after 7 min of
heat exposure, 80% of cell death occurred [73].
An overview of AuNP application and conditions in thermal therapy of cancer is presented in
Table 2.
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Table 2. Summary of AuNPs application in the thermal ablation of cancer (GFR: epidermal growth factor receptor).
Type of NP/NP with a
Surface Coating
Nanoparticle
Size
Injection
Dose/Nanoparticle
Concentration
Injection
Route
Exposure
Conditions
Thermal
Ablation Type Type of Tumor
Temperature,
◦C Cell Death Reference
AuNP—anti-EGFR
antibody coated 40 nm N/A intratumoral
57 W/cm2,
514 nm, 4 min
Laser
photothermal
therapy
Epithelial carcinoma
HaCaT cells N/A 100% [72]
AuNP—citrate coated 13 nm N/A intratumoral 10–100 W, 7 min Radiowaveablation
HepG2 cancerous
cells >50
◦C 80% [73]
AuNP 5 nm 67 µM/L intratumoral 13.56 MHz,5 min RF ablation
Hepatocellular
(Hep3B) and
Pancreatic cancerous
cells (Panc-1)
N/A
99.8 ± 3.1
Hep3B
96.5 ± 8.4
Panc-1
[74]
AuNP—anti-EGFR
coated N/A N/A intratumoral 200 nW
Laser
photothermal
therapy
Cancerous cell 70–80 ◦C N/A [69]
AuNP—anti-EGFR
coated 20 nm N/A intratumoral
13.56 MHz,
200 S, 10−15 kV/m RF ablation
Pancreatic cancerous
cell line N/A Panc-1 61% [76]
AuNP—PAM4
hemi-antibody coated
and AuNP—C225
antibody-coated
36.9 ± 1.5 nm
32.6 ± 0.7 nm 100 µg/mL invivo 600 W, 10 min RF ablation
Panc-1 and Capan-1
pancreatic carcinoma
cell lines
N/A N/A [75]
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4. CuS Nanoparticles
Semiconductor copper sulfide (CuS) nanomaterials display good optical, electrical, and catalytic
properties by absorbing the infrared light from energy band–band transitions. CuS nanoparticles
found wide application in biological labeling, the detection of DNA, eye protection, monitoring the
laser light, and the photodegradation of pollutants. CuS nanoparticles are promising due to their
minimal cytoxicity effects, which is similar to the gold nanoparticles, and low cost [79]. The minimal
cytotoxicity of CuS nanoparticles is explained by the slow rate of dissociation rate of Cu ions [80].
The CuS nanoparticles are mainly used in the photothermal therapy of cancer with the size
range as low as 3 nm. Li et al. were the first to study the photothermal ablation of cancerous cells
utilizing the heat generated by the interaction of CuS nanoparticles when NIR light was applied
in 2010. The research was performed using 3-nm uniformly distributed thioglycolic acid-stabilized
CuS nanoparticles with a density of 4.6 g/cm3 for the photothermal ablation (PTA) of Human cervix
adenocarcinoma (HeLa) cells. The intensive absorption of the NIR by CuS nanoparticles enables
their use in PTA therapy. When CuS particles with the concentration of 770 µM (approximately
1.42 × 1014 particles/mL) labeled cell lines were exposed to a laser beam at 808 nm with the output
power of 24 W/cm2, the temperature increased by 12.7 ◦C and reached 37 ◦C in 5 min. No changes were
observed when water was used at the same conditions. This research demonstrated the dependence of
cell death on the nanoparticles concentration and the laser’s output power. Moreover, in comparison
with nanostructures, CuS nanomaterials offer several advantages. First, CuS is cheaper than gold.
Second, the absorption wavelength of CuS nanomaterials do not depend on the particle size, shape,
or solvent due to the NIR absorption in CuS arising from the d–d transition of Cu2+ ions, while in
AuNPs, the NIR absorption occurs from the surface plasmon resonance. Finally, the 3-nm CuS
nanoparticles can offer the desired pharmacokinetic properties for targeted delivery. However, the
properties of CuS nanoparticles are limited by the low efficacy of the photothermal conversion [79].
Near-infrared light-responsive inorganic nanoparticles can increase the efficiency of cancer
photothermal ablation therapy. Moreover, CuS nanoparticles can be used in the combination of
photothermal therapy with immunotherapy, as it was proposed in the study of Guo et al. [81].
The advantage of current research consists of the ability to utilize the chitosan-coated hollow copper
sulfide nanoparticles (HCuSNPs) with a porous shell structure for the treatment of metastatic cancer.
These nanoparticles were composed of small crystals with a diameter of 10 × 2 nm. This research
demonstrated that the combination of photothermal therapy and immunotherapy was more efficient
for the tumor treatment than when they were used separately. The results of this study were compared
to previously published data, where regularly injected pegylated HCuSNPs were eradicated through
both renal and hepatobiliary excretion. This study demonstrated a comparatively higher amount of Cu
eradication, which is 47% from tumors. This was associated to photothermally activated disintegration
of the original ∼85-nm HCuSNPs into ∼10-nm small CuS nanoparticles, providing faster clearance
from the tumor [81].
Huang et al. in 2014 investigated the application of 3.8-nm sized hydrophobic copper sulfide
nanoparticles with a phospholipid–PEG coating (CuS@DSPE-PEG NPs) for the treatment of cervical
cancer with HeLa cells in mice, applying the photothermal ablation. The team incubated nanoparticles
with several concentrations to damaged cells and exposed them to an 808-nm laser with a power
density of 1.0 W cm2 for 8 min in order to investigate their influence on the death rate of cells. A total
of 80% cell death appeared at a 400 mg/mL concentration of CuS@DSPE-PEG NPs. Further research
was conducted to examine the in vivo photothermal effect of CuS@DSPE-PEG NPs employing the
S180 tumor-bearing Kuming mice. A tumor surface temperature above 59.2 ◦C was achieved promptly
within 5 min, while in the control group not containing nanoparticles, the temperature reached
about 48 ◦C in mice [82]. Another study employing PEGylated CuS nanoparticles was conducted by
Zhou et al. The research utilized the developed PEG-coated single radioactive copper sulfide (CuS)
nanoparticle platform to enhance the efficacy of photothermal therapy (PTT) in a murine orthotopic
model of anaplastic thyroid carcinoma (ATC). The investigation of temperature elevation induced
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by NIR light irradiation was carried out in the presence of PEG-CuS NPs using a continuous-wave
fiber-coupled diode laser centered at 980 nm. Exposure to the NIR laser light at 2.5 W/cm2 elevated
the temperature of the CuS NP solution with 400 mg/mL of 0.1-mm CuS NPs from 23 ◦C to 98 ◦C in
10 min. The temperature of pure water was elevated only from 23 ◦C to 32 ◦C during the same period.
In addition, tissue distribution of polyethylene coated (PEG-[64Cu]) CuS NPs could be imaged and
quantified by Positron Emission Tomography allowing dosimetry calculation and potential for the
prediction of thermal dose [83].
Table 3 provides a summary of CuS NPs size, exposure conditions and temperature increase in
the thermal therapy of cancer.
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Table 3. Summary of Cu-based nanoparticles application in the thermal ablation of cancer (CuSNPs: hollow copper sulfide nanoparticles).
Type of
Nanoparticle/Nanoparticle
with a Surface Coating
Nanoparticle
Size
Injection
Dose/Nanoparticle
Concentration
Injection
Route
Exposure
Conditions
Thermal
Ablation Type Type of Tumor Cell Death
Temperature,
◦C Reference
Thioglycolic acid-stabilized
CuS NPs 3 nm 4.6 g/cm
3, 770 µM intratumoral 24 W/cm
2
for 5 min
photothermal
ablation HeLa cells 55.6 ± 5.8%
Increased to
12.7 ◦C [79]
Chitosan-coated HCuSNPs 10 × 12 nm intratumoral photothermalablation [81]
Phospholipid-PEG coated–
CuS NPs 3.8 nm 400 mg/mL
−1 intratumoral 1.0 W cm
2,
8 min
Photothermal
ablation HeLa cells >80% Max 59.2
◦C [82]
PEG coated—CuS NP N/A 400 mg/mL,0.1 mm intratumoral 2.5 W/cm
2 Photothermal
ablation
Anaplastic
thyroid carcinoma N/A Max 98
◦C [83]
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5. Nanorods
Gold nanorods are the unique class of metal nanostructures with two surface plasmon absorption
long and short wavelength bands. The strong long wavelength band lies in the NIR region due to
the longitudinal oscillation of the conduction band electrons, and the weak short wavelength band
is around 520 nm because of the transverse electronic oscillation. The surface electric field enlarges
because of the surface plasmon excitation, which facilitates strong absorption and the scattering of
electromagnetic radiation by gold nanorods. Gold nanorods can be used in biomedicine due to their
tunable optical absorption and scattering properties [84,85]. Gold nanorods gained attraction in
photothermal therapy due to the possibility of their synthesis with various aspect ratios, which enable
selective absorption in the NIR region [86,87]. A TEM image of gold nanorods is shown in Figure 9.
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seed-to- (III) i gro t edia. ( – ) ol nanoro s ere grown with cetyltripropyla oniu
bro i e (D–F) gold anorods grown with CTAB [Repro uced from [88,89],
with permissi n from Open Access Journal, und r th license CC BY 4.0, Copyright 2017].
The ost co only used surface coating for nanorods is polyethylene glycol (PEG).
The advantages of using PEG in its affinity to cell membranes, leading to a high tumor uptake
rate [90]. In addition, PEG is available in different polymer lengths. The nanoparticles coated with PEG
are stable, biocompatible, and nontoxic for in vitro application [24]. Von Maltzahn et al. developed
long circulating PEG-coated gold nanorods and compared their effects with the efficacy of nanoshells.
The authors simulated a therapeutic irradiation regimen based on heat transfer simulations, which are
able to successfully plan the therapy to destroy tumors on mice injected with PEG-NRs using half the
light intensity of previous nanoshell therapies [91].
a g et al. i vestigate t e effects of gol a oro s i rostate ca cero s cells si g a
(continuous ave) laser e itting at 800 n , 20 /c 2, sing ifferent ex os re ti es ranging fro
4 min to 20 min. They found an acceptable agreement between the theoretically predicte results and
experimental ones [92].
The theoretical investigation of the effect of the distribution of nanorods delivered to a skin tumor
for the thermal ablation procedure was reported by Soni et al. Three distribution arrangements of gold
nanorods with 5-nm iameters and 2.5-m epth were considered: uniformly distribute within the
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tumor region, deposited in the tumor core, and accumulated at the tumor periphery area through
intravenous injection. In the first case, the temperature increased up to 75 ◦C at the surface of a tumor.
However, the lower temperature change was achieved at the tumor depth, comparatively, at 2.5 mm
and 5 mm, for which the temperature was about 48–58 ◦C and 43–48 ◦C, respectively. For the second
case, the top half-central region of the tumor reached a temperature of 50–65 ◦C, and the deeper
tumor location remained at 37 ◦C. Finally, the concentration of gold nanorods at the periphery of the
tumor area led to a uniform temperature distribution and demonstrated better heat release to the
deeper tumor region, reaching the temperature of 48–52 ◦C. The photothermal irradiation intensity of
1.25 W/cm2 for 300 s at a volume fraction of 0.001% were determined as an optimal parameter to obtain
the temperature value higher than 53 ◦C over the whole tumor region [93].
Cho et al. proposed the study of photothermal laser ablation using PEGylated gold nanorods
conjugated with C-225, which is a recombinant, human/mouse chimeric monoclonal antibody to
epidermal growth factor receptor (αEGFR). A fiber-coupled diode laser (DILAS) emitting at 808 nm
was used in thermal ablation experiments. The spot size was approximately 5 mm2 and the cells
were exposed at an irradiation time of 1 minute with varying laser power densities from 20 W/cm2
to 90 W/cm2 or at 20 W/cm2 with varying irradiation times from 30 s to 3 min. Upon reviewing
the binding assay results for various Monomethoxy PEG thiol (mPEG-SH) concentrations, 4 mg/mL
showed the most uniform fluorescence with the least agglomeration, and was used for the in vitro
thermal ablation experiments. Moreover, in the control samples treated with C-225 only, no cell death
was observed until the power density was increased to 90 W/cm2, which was the highest level used in
these experiments. In contrast, samples treated with αEGFRAuNR showed clear trypan blue staining,
indicating cell death, at a laser power level as low as 20 W/cm2 [94].
Mooney et al. in 2015 and 2017 investigated the effects of laser ablation enhanced by gold
nanorods. Experiments were performed on mice. Firefly luciferase expressing MDA-MB-231 human
breast cancerous cells were injected into the flank of the animals, and the ablation was performed
on subcutaneous tumors (growth on the flank of each mouse). The tests were performed at different
nanorod masses (0, 12.5, 25, and 50 µg per tumor), laser powers (1.4 and 2 W/cm2), and treatment times
(0.5, 1, 2, and 5 min). The results showed that the higher the concentration, the higher the temperature
increase during the laser ablation. For instance, at 2 W/cm2, the control group (without nanorods)
showed a temperature increment of approximately 15 ◦C, while the group treated with 2 W/cm2 and
50 µg of nanorods experienced a temperature increment of approximately 23 ◦C. The temperature
increment also influenced the effects of the laser ablation: in the control group, the laser ablation was
not successful, while the group with 50 µg of nanorods experienced a full resorption of the tumor
(Figure 10) [95,96].
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Figure 10. AuNRs-mediated LA in mice bearing MDA-MB-231 human breast cancer. Temperature
evolutions measured nside the tumor during blation performed at 2.1 W and 3 W. Xenogen images
acquired two days after blation [Reproduced from [96], with permission from Taylor & Francis,
Copyright 2019].
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Dickerson et al. proposed the study of photothermal therapy of HSC-3 human squamous carcinoma
cells in mice by the intravenous injection of PEGylated gold nanorods with dimensions 12 nm in width
and 50 nm in length (4.0 aspect ratio), with a longitudinal plasmon absorption maximum at 800 nm.
Quick heating occurred upon exposure, followed by steady-state equilibrium, and more than 90% of the
observed temperature rise happened within the first 3 min [97]. Jang et al. investigated photothermal
ablation using different concentrations of PEG-coated gold nanorods. In each experimental set, the final
particle concentration of I gold nanorods n the polyacrylamide phantom was 0.0, 0.1, 0.25, 0.5, 1.0,
2.0, or 5.0 nm. Each gold nanorod-suspended phantom was illuminated with light from an 810-nm
diode laser. A relatively uniform distribution of temperature was observed in phantoms with a 5-nm
concentration of gold nanorods. Non-uniform temperature distribution along the depth of a phantom
was observed in phantoms comprising a higher concentration of GNRs. For instance, the temperature
at the top part of the phantoms reached more than 60 ◦C, while 35 ◦C was recorded at a distance
6 mm from the surface of a phantom. The difference in temperature at 2-mm and 10-mm distances of
illumination was comparatively small at low concentrations of gold nanorods (0.1, 0.25, and 0.5 nm),
compared to high concentrations (1.0, 2.0, and 5.0 nm). The study concluded that time and power laser
irradiation help to control the temperature in the deep region of a phantom [98].
Huff et al. investigated the effect of gold nanorods on adherent human KB cells (the cell line
extracted from oral epithelium) thermal therapy by changing the titanium to a sapphire laser. KB cells
treated with CTAB-coated nanorods were exposed to continuous wave irradiation for 30 s, at fluences
ranging from 15 to 120 J/cm2. These cells were destroyed at 30 J/cm2 with the harsh bubbling of their
membranes after 30 s of irradiation. This study demonstrated that nanorods can be induced at much
lower power densities, and cells are not required to be internalized fully to provide photothermal
damage [86].
The parameters and conditions of cancer thermal ablation using gold nanorods are summarized
in Table 4.
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Table 4. Summary of nanorods application in the thermal ablation of cancer (PEG: polyethylene glycol).
Type of
Nanorods/Nanorods
with a Surface Coating
Nanorod
Size/Concentration
Injection
Dose/Nanorods
Concentration
Injection
Rote Exposure Conditions
Thermal
Ablation Type Type of Tumor Cell Death Temperature,
◦C Reference
AuNP 5 nm 0.001% volumefraction intratumoral 1.25 W/cm
2, 300 s
photothermal
therapy Skin tumor Total cell death
75 ◦C at tumor
surface,
43–48 ◦C at tumor
depth
[93]
PEGylated gold
nanorods–
C225 antibody
3 mm 4 mg/mL intratumoral
20 W/cm2 to 90
W/cm2, from 30 s to
3 min
photothermal
laser ablation HTB-9 cells N/A N/A [94]
PEGylated gold
nanorods
dimensions 12 nm
in width
and 50 nm in length
N/A intravenous 3 min photothermaltherapy
HSC-3 human
squamous
carcinoma cells
>90% N/A [97]
PEG-coated gold
nanorods N/A N/A intratumoral
2 W cm–2,
5 min.
photothermal
ablation Cancer tumor N/A 50–52
◦C [98]
gold nanorods N/A N/A intratumoral 30 J/cm2, 30 s
photothermal
laser ablation human KB cells N/A Increased by 5
◦C [86]
PEG-coated gold
nanorods N/A
20 mg Au/kg in
PBS intravenous 2 W cm
–2, 5 min
photothermal
ablation
MDA-MB-435
human
cancerouscells
Within 10 days all the
irradiated,
PEG-NR-targeted tumors
completely disappeared
over 70 ◦C [91]
gold nanorods N/A N/A intratumoral 20 W/cm2, 4 to 20 min
photothermal
ablation
prostate
cancerouscells N/A N/A [92]
gold nanorods N/A N/A intratumoral 1.4 and 2 W/cm
2, and
0.5, 1, 2, and 5 min
photothermal
ablation
MDA-MB-231
human breast
cancerous cells
N/A About 55 ◦C [95,96]
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6. Carbon Nanotubes (CNTs)
Single-walled CNTs are cylinders of nanometer size consisting of a single graphene sheet wrapped
up to form a tube (Figure 10) [99,100]. CNTs can be differentaiated as single-walled nanotubes (SWNTs)
and multi-walled nanotubes (MWNTs) (Figure 11), depending on the number of graphene layers from
which the nanotubes are composed [101]. There are several known CNT synthesis techniques: carbon
arc discharge, laser ablation of carbon, and chemical vapor deposition. Nanotube diameters range
from 0.4 to 3 nm for SWNTs and from 1.4 to at least 100 nm for MWNTs [102]. CNTs are distinguished
by their physical and chemical properties, and have been intensively explored for biological and
biomedical applications in the past few years [103]. SWNTs have strong optical absorption properties
in the near-infrared (NIR) range [101,104,105]. Single-walled carbon nanotubes generate significant
amounts of heat upon excitation with near-infrared light at 700 to 1100-nm wavelengths, which is
transparent to biological systems, including skins, and hardly absorbed by normal tissue [106]. CNTs
have the opportunity to be employed not only in imaging but also for drug delivery and thermal
ablation. This is mainly because of the characteristics of these materials, including their unique
chemical, physical, and biological properties, nanoneedle shape, hollow monolithic structure, and their
ability to obtain the desired functional groups on their outer layer [107,108].
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Figure 11. Schematic overview of single-walled nanotubes (SWNTs) and multi-walled nanotubes
(MWNTs) [Reproduced from [109] with license CC BY 4.0, Copyright 2017].
CNTs can convert NIR laser radiation into heat that is reasoned by the photon–phonon and
electron interactions [110]. This property of carbon nanotubes leads to the wide application of them in
biomedical application, especially in thermal therapy for cancer. In order to achieve the specific tumor
cell targeting, as well as improve the biocompatibility and cell-penetrating capability, the surface of
carbon nanotubes need to be functionalized [111–113].
Gannon et al. discovered the ability of SWNTs to release heat in an RF field, which can be
employed to yield the thermal cytotoxicity in tumors. The research was conducted to investigate the
treatment of three cell lines such as HepG2 and Hep3B hepatocellular cancer cells and Panc-1 pancreatic
adenocarcinoma cells. The cells were incubated at several concentrations (5 mg/L, 50 mg/L, 125 mg/L,
250 mg/L, and 500 mg/L) of biocompatible polymer functionalized SWNTs and exposed to RF ablation
at a 13.56-MHz frequency and power value of 800 W for 1 or 2 min. Total (100%) cytotoxicity in all
three cell lines was determined at high concentrations of SWNTs (500 mg/L) after 2 min of RF exposure,
demonstrating the relevance of concentration [114].
The study on breast cancer treatment using carbon nanotubes coated with anti-Her2+ antibody
was conducted by Marches et al. The research set out to determine the efficiency and selectivity of the
NIR-mediated thermal ablation of Her2+ human breast carcinoma cancer cells. Cells were irradiated
with 808-nm light at 9.5 W cm−2 for 4 min. The efficiency of cell killing increased, and was greater than
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90% by 24 h. This study demonstrated that Her2+ cells internalized with CNTs were more sensitive to
NIR-mediated photothermal destruction compared to the cells with CNTs on their surface [115].
The photothermal treatment of colon cancer employing the SWNTs was investigated by
Hashida et al. For that purpose, SWNTs were combined with a (KFKA)7–peptide composite.
The surface-functionalized samples at concentrations of 0.75 µg/mL for colon 26 and 2.5 µg/mL
for HepG2 cells, respectively, underwent the NIR laser irradiation. The research demonstrated a high
rate of cell death rate and temperature rise up to 43 ◦C in 30 s for both cell lines [116].
Fisher et al. investigated the capability of MWNTs coupled with laser irradiation to increase
the tumor treatment temperature and destruction of cells. A human androgen-independent prostate
cancer cell line (PC3) and murine renal cancer cell line (RENCA) were laser irritated at 15.3 W/cm2
and a 5-mm beam diameter for 1.5 and 5 min using 900-nm MWNTs. Larger temperature elevations
were observed for both samples at 5 min of ablation, and reached 43 ◦C compared to the control
sample without MWNTs, where the temperature increase was observed at 7 ◦C. However, the use of
MWNTs caused differences in cell viability [117]. The study by Mocan et al. demonstrated the ex vivo
laser-mediated ablation of selectively targeted pancreatic cancer Panc-1 cells using human albumin
bound to MWCNTs. The ablation of the tumor was done for 30 min using a 5 W/cm2 808-nm continuous
laser generator. The temperature changes in 20 min were recorded as 4.2 ◦C in the surrounding healthy
tissue, 25.6 ◦C at the periphery of the tumor, and 29.3 ◦C in the central region of the tumor, showing
that the temperature is higher in the center. The high value of temperature that was able to produce
extensive tumor necrosis was achieved in 20 min [118]. Table 5 summarizes thermal ablation of cancer
using carbon nanotubes.
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Table 5. Summary of carbon nanotubes application in the thermal ablation of cancer.
Type of Carbon
Nanotubes/Carbon
Nanotubes with a
Surface Coating
Carbon
Nanotube
Size
Injection
Dose/Carbon
Nanotube
Concentration
Injection
Route
Exposure
Conditions
Thermal
Ablation Type Type of Tumor
Cell
Death
Temperature,
◦C Reference
SWNT–polymer coated N/A 50 mg/mL intratumoral 600 W,13.56 MHz RF ablation
human cancer cell lines
(HepG2, Hep3B and
Panc-1
100%
Increase by
1.6 ◦C
per second
[114]
Carbon
nanotube—anti-Her2+
antibody coated
N/A N/A intratumoral 9.5 W cm
−2,
4 min
laser ablation Her2+ human breastcarcinoma cancer cells 90% N/A [115]
Carbon
nanotube—(KFKA)7
–peptide coated
N/A
0.75 µg/mL
for colon26 cells
2.5 µg/mL
for HepG2 cells
intratumoral 30 s photothermaltherapy Colon and HepG2 cells N/A 43
◦C [116]
Multi-walled
carbon nanotube 900 nm N/A intratumoral
15.3 W/cm2,
5 min
laser ablation
prostate cancer cell line
(PC3) and murine renal
cancer cell line (RENCA)
N/A 43 ◦C [117]
Carbon nanotube—
human
albumin protein coated
N/A N/A Ex vivo 5 W/cm
2,
20 min
laser-mediated
ablation
pancreatic cancer Panc-1
cells N/A
29.3 ◦C at
tumor
centre
[118]
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7. Nanoshells/Nanocomposites
7.1. Nanoshells
Nanoshells are a class of nanoparticles with 1–20 nm thin coating over the core that can be
fabricated of a different material. The properties of nanoshells are possible to adjust by varying the
core-to-shell ratio [119,120], as in Figure 12a,b. By varying the thickness of the core and shell, nanoshells
can be produced to have light absorbing or scattering properties at the desired wavelength across
visible and NIR wavelengths. This explains their optical tunability and makes it possible to fabricate the
nanoshells with a peak optical absorption in the NIR [121]. As a NIR absorber, nanoshells are optically
very robust; their rigid structure and noble metal surface allow to have the stability to chemical and
thermal denaturation and photobleaching effects than conventional NIR dyes [119]. Nanoshells can be
accumulated at the tumor area, absorb the NIR light, and produce heat locally to destroy the cancer
cells [9].
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observed, while at 90 days post-treatment, all the mice remained healthy [121].  
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carried out by Stern et al. The experiments investigated the treatment of prostate tumors in mice 
Figure 12. (a) Silica core–gold shell nanoshells [Reproduced from [122], with permission from Elsevier,
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The most common type of nanoshell composition is silica–gold. The frequently used size of
nanoshells are 100–150 nm for the shell and 8–10 nm for the core. The size of nanoshells is explained by
the ability to absorb the light in the first and second NIR window. The first NIR window corresponds to
650–850 nm, while the second NIR window corresponds to 950–1350 nm. At these wavelength ranges,
light can penetrate the normal cells and reach the nanoshells bound to the tumor [124]. The studies
demonstrated that the mainly used wavelength range is 800 nm, because at this NIR window, the light
can permeate the tissue securily [119,121,124,125].
Hirsh et al. have first proposed the study on the use of silica–gold nanoshells where the core
diameter is 110 nm and the gold shell thickness is 10 nm. These nanoshells’ peak absorbance at 820
nm employed for an in vivo study in mice of photothermal carcinoma with breast cancer SK-BR-3
cells treatment under the 35 W/cm2 for 7-min laser exposure conditions. The research demonstrated
an average temperature increase of 37.4 ◦C in 4–6 min at the laser dosages that were 10-fold to 25-fold
less co pared to previous studies [119]. O’Neal et al. proposed the research for the laser treatment of
CT26.WT murine colon carcinoma tumor cells in mice using the PEGylated nanos ells with a 8–10-nm
thick gold shell over the 110-nm silica core. Nanosh lls with 805–810-nm peak optical absorption
could i crease the treatment temperature up to 50 ◦C in 30 s, administering 2.4 × 1011 nanoshells/mL
solution in mice. Within 10 day , h complete resorption of the tumor was observed, while at 90 days
post-treatment, all the mice remained health [121].
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Another study on the thermal therapy of cancer cells using the silica–gold nanoshells was carried
out by Stern et al. The experiments investigated the treatment of prostate tumors in mice using a 110-nm
silica core and 10-nm gold-coated nanoshells by intravenous injection and the application of a NIR laser
at 808 nm. Tumors were observed over 21 days and demonstrated 93% tumor necrosis and regression
in a high-dose treated group. The temperature was increased up to 65.4 ◦C. However, limitations exist
in quantifying the delivery of nanoshells [126].
Bernardi et al. proposed a method for the in vitro photothermal ablation of medulloblastoma and
glioma cell lines using anti-HER2 and anti-IL13Ra2 antibody labeled nanoshells (core: 100-nm silica,
shell: 10-nm gold) with peak light absorption at 800 nm in the NIR region. The results demonstrated
that the implemented approach can selectively kill medulloblastoma cells that express HER2 without
killing cells that do not express HER2. In addition, the research showed that the dual requirement for
the presence of both nanoshells and laser light to induce cellular death is particularly promising for
application in brain tumors [125]
The application of nanoshells in both imaging and therapy approach has shown promising results
for specific cancerous cells. In their in vitro study, Loo et al. demonstrated first detecting by imaging
and then thermally ablating human breast cancer cells that overexpress HER2 using immunotargeted
nanoshells that have been designed to both scatter and absorb light within the NIR [127]. Schwartz et al.
proposed an in vivo study of the minimally invasive treatment of canine prostate cancer in male
dogs using 150 nm in diameter spherical gold-over-silica nanoshells with an absorption region that
peaks near 800 nm. NIR radiation was provided by a 15-W gallium arsenide diode laser. The results
demonstrated the possibility of ablative thermal lesions. Moreover, the study suggested that an optical
fiber applicator can have precise tumor ablation [128]. Finally, Xu et al. conducted research on the
application of graphitic carbon-coated ferromagnetic cobalt nanoparticles (C–Co-NPs) with diameters
of around 7 nm with a 2.5 µg mL−1 concentration and cubic crystalline structures for the RF ablation of
mammalian cervical cancer cells (HeLa cells). The study demonstrated the destruction of 63% of the
cells within 10 min of RF ablation under the 350-kHz and 5-kW parameters [129].
7.2. Nanocomposites
The term nanocomposite describes a class of composites consisting of two or more materials,
where one of the phases has at least a dimension less than 100 nanometers. Compared to nanoshells,
nanocomposites can have micron-sized components (Figure 13).
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Xu et al. conducted research on RF treatment of human cancer cell line Panc-1 using highly
biocompatible luminescent superparamagnetic nanocomposites Fe3O4 nanoparticles coated with
a silica shell, Fe3O4/SiO2 (IOS), and water-soluble CdSe-ZnS quantum dots (QDs). Panc-1 cells were
cultured with various concentrations of nanocomposites and exposed to a frequency of 350 kHz.
This study demonstrated the influence of nanocomposite concentration on the rate of cell death. Thus,
0.83 µg/mL nanocomposite could achieve 82.2–83.8% of total cells death, while at nanocomposite
concentrations up to 1.66 µg/mL, the cell death value reached 98.7–99.2% in 10 min [131].
Shi et al. in his work developed a dual-nanostructure modified graphene-based nanocomposite
by growing a layer of gold nanostructures on the synthesized iron oxide nanoparticles on top of
graphine oxide (GO-IONP), obtaining a GO-IONP-Au nanocomposite (graphine oxide-iron oxide
nanoparticle and gold nanocomposite), which was then functionalized with PEG. Female BALB/c mice
bearing 4T1 tumors were intratumorally injected with 40 mL of 50 mg/mL Pegylated nanocomposite
GO-IONP-Au-PEG and then subjected to the 808-nm laser irradiation at the power density of 0.75 W/cm2
for 5 min. The study showed that the surface temperature of the tumor injected with GO-IONP-Au-PEG
rapidly increased to about 55 ◦C within 5 min of laser irradiation [132].
An overview of cancer thermal ablation using nanoshells and nanocomposites is presented in
Table 6.
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Table 6. Summary of gold nanoshells/nanocomposite application in thermal ablation of cancer (NIR: near infrared).
Type of
Nanoshells/Nanocomposites
(Core/Shell)
Size and/or
Core/Shell
Thickness
Injection
Dose/Concertation
Injection
Route
Exposure
Conditions
Thermal
Ablation Type Type of Tumor
Temperature,
◦C
Cell
Death Reference
Gold nanoshells
(silica/gold) 110 nm/10 nm N/A intratumoral
35 W/cm2,
7 min
photothermal
therapy
breast cancer
SK-BR-3 cells >37.4
◦C N/A [119]
Gold nanoshells
(gold/PEG) 110 nm/8–10 nm
100 µL of
2.4 × 1011
nanoshells/mL
solution
intratumoral 10 days laser ablation
CT26.WT
murine colon
carcinoma
tumor cells
50 ◦C 100% [121]
Gold nanoshells
(silica/gold) 110 ± 11 nm/10 nm
8.5 µL/gm
body weight intratumoral 21 days
NIR laser
ablation
prostate cancer
tumor 65.4
◦C 93% [126]
anti-HER2—silica core nanoshell
anti-IL13Ra2
antibody—silica
core nanoshell
(silica/gold)
100 nm and 10 nm 32.61 and48.52 mg/g intratumoral N/A
photothermal
ablation
medulloblastoma
and glioma cell
lines
N/A 100% [126]
Gold nanoshells
(silica/gold) 150 nm N/A intratumoral
3.5 W for
3 min laser ablation
canine prostate
cancer N/A 100% [128]
Graphitic carbon coated
C–Co-NPs 7 nm 20 µg mL
−1 intratumoral 350 kHz,5 kW, 10 min RF ablation HeLa cells N/A 98% [129]
Fe3O4 nanoparticles–
silica shell
(silica/Fe3O4)
N/A 1.66 µg/mL intratumoral 350 kHz,10 min RF ablation Panc-1 cell line N/A
98.7–
99.2% [131]
GO-IONP-Au-PEG N/A 50 mg/mL intratumoral 0.75 W/cm
2,
5 min
Laser ablation 4T1 tumor cells Max55 ◦C N/A [132]
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8. Conclusions
Despite a wide range of research conducted for the thermal therapy of cancer tumor, there are
still existing limitations. It is hard to obtain a highly accurate method for temperature monitoring
within the whole tumor due to the inhomogeneous distribution of MNPs. A key factor in the success of
any nanoparticle-based therapy is the ability to understand and/or control nanoparticle accumulation
within the tumor. Thus far, scientists have found many ways to destroy cancer cells in vitro and
in vivo in mice, but the translation to commercial clinical use has not yet occurred. Nanomaterials
offer a wide range of magnetic and optical properties that can be implemented in cancer therapy under
different ablation sources (Table 7). All the studies described in this paper used different nanomaterials,
but factors such as size, shape, surface coating, injected dose, animal model, and cancer model were all
different, and can make a comparison between the studies a significant challenge. The importance
of size on thermal therapy is well investigated and revealed that it is beneficial to use the particles
that were between 10–40 nm. However, larger nanoparticles can also be administered into the tumor,
but there are still some gaps in the research regarding the heterogeneity of endothelial cells gaps and
the penetration of nanoparticles. Also, despite the demonstrations of scaled-up synthesis, nanomaterial
synthesis is notorious for being irreproducible, and no two nanoparticle batches are the exact same.
Variation in nanoparticle structure/composition may affect tumor-targeting ability and penetration
along with photothermal heating efficiency. In addition, the toxicity of nanomaterials is not well
understood, and could also vary with structure/composition [34]. Among the disadvantages and key
challenges to employing thermal therapy using nanomaterials are the inhomogeneous distribution of
nanoparticles, lack of noninvasive technique for biodistribution assessment, lack of treatment planning
tools to predict temperature distributions, and increasing patient’s complexity due to the injection of
nanoparticles. Therefore, further work and broad investigations are required in this field.
Table 7. Summary on types of nanoparticles and ablation techniques.
Type of Nanoparticles/Source of Ablation RF MW Laser Ablation Photothermal Ablation
Magnetic nanoparticle
Gold nanoparticle
Cu-based nanoparticle
Nanorod
Carbon nanotubes
Nanoshell/Nanocomposite
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